These compounds may interact with:
Hypoxia-inducible factor 1-alpha
Potentially involved in: carcinoma; cancer; vascular disease; hemangioma; polycythemia; anaplasia; astrocytoma; bipolar disorder; noninfiltrating intraductal carcinoma; brain ischemia; cholangitis, sclerosing; mental depression; glioblastoma; congenital heart defects; cardiomegaly; heart failure; hyperplasia; hypertensive disease; pulmonary hypertension; biliary cirrhosis
Disease data sourced from Pharos.